综合性多组学和门德尔随机化确定WWOX和THBS2作为成熟T/NK细胞淋巴瘤的潜在治疗点
Yinjie Qin1, Jiayue Wei1, Yingzhi He1
1Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, 510282, China.
Journal of translational medicine
|November 19, 2025
概括
这项研究确定了WWOX和THBS2作为成熟T/NK细胞淋巴瘤的关键点,提供了新的精确治疗方向. 表观遗传重编程和免疫微环境调制显示出治疗这种侵袭性癌症的前景.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 成熟的T/NK细胞淋巴瘤是一种侵略性的非霍奇金淋巴瘤,在复发/耐药病例中结果不佳.
- 有限的特定治疗点需要新的治疗策略.
- 了解分子机制对于开发有效疗法至关重要.
研究的目的:
- 通过多omics数据集成,识别和验证成熟T/NK细胞淋巴瘤的新型治疗点.
- 探索潜在目标的遗传调节机制和生物功能.
- 评估针对已识别的因素的治疗潜力和风险益处概况.
主要方法:
- 综合的全基因组关联研究 (GWAS),cis-eQTL,cis-pQTL和cis-mQTL数据使用门德尔随机化 (MR) 和贝叶斯协同定位.
- 基于总结数据的MR (SMR) 用于因果推断和转录组分析用于功能评估.
- 利用全现象MR进行风险效益评估和药物预测/分子对接以评估治疗潜力.
主要成果:
- 确定了WWOX作为一种保护因素,THBS2作为一种具有强烈局部化的成熟T/NK细胞淋巴瘤的危险因素.
- SMR分析表明WWOX表达,DNA甲基化和疾病风险之间存在关联.
- 转录组分析揭示了WWOX和THBS2在瘤扩散,入侵和免疫调节中的作用;全现象MR突出了针对THBS2抑制的组织特异向.
- 药物预测表明了表观遗传调节药物的潜力.
结论:
- 确定WWOX和THBS2是成熟T/NK细胞淋巴瘤的有希望的治疗点.
- 针对WWOX和THBS2的表观遗传重编程和免疫微环境调节为精密疗法提供了新的途径.
- 这项研究为开发耐火性成熟T/NK细胞淋巴瘤的向治疗提供了基础.
相关概念视频
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
Canonical Wnt Signaling Pathway
10.4K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.4K
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
B Cell Activation and Differentiation
15.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


